NEW · Health Care
ABT
Abbott Laboratories · $168.71B
97.50
+0.84%
Price
21 sessions shownTechnicals
from daily closesRSI · 14 day
25.1
Avg true range · 14d
2.06%
Volatility · 20d annualised
18.3%
Trend · 20d vs 50d
—
vs 20-day average
-4.61%
vs 50-day average
—
vs 200-day average
—
200-day average
—
Internals
where it sits, and how hard it is being traded52-week low
81.97
52-week high
135.37
Volume vs its 20-day avg
—
Beta vs the market
0.55
Sitting 29% of the way up its 52-week range (81.97 → 135.37)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Sep 22
104.54
Turned up · Sep 17
100.33
Fundamentals
P/E
31.10
Fwd P/E
—
P/S
3.62
P/B
4.18
EV/EBITDA
21.11
ROE
10.5%
ROA
5.6%
Gross margin
56.8%
Net margin
—
Debt / equity
0.25
Rev growth
8.1%
EPS growth
-1.7%
Earnings
Beat in last 4
1 of 4
2026-06-30reported 1.31 vs 1.29 expected+1.4%
2026-03-31reported 1.15 vs 1.16 expected-0.5%
2025-12-31reported 1.50 vs 1.51 expected-0.7%
2025-09-30reported 1.30 vs 1.31 expected-1.1%
Analyst coverage
33 analysts · as of 2026-09-01Strong buy
12
Buy
13
Hold
8
Sell
0
Strong sell
0
Every figure here is measured from live market data as of Oct 4, 05:47 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.